Zai Lab reports positive data from Phase Ib psoriasis therapy trial
At four weeks, ZL-1102 offered a 45% relative improvement in the local PASI score of the target lesion versus placebo.
Agilent Benefits of Quality Control WP
At four weeks, ZL-1102 offered a 45% relative improvement in the local PASI score of the target lesion versus placebo.
